Background: Nasopharyngeal carcinoma (NPC) is a type of malignant tumors commonly found in Southeast Asia and China, with insidious onset and clinical symptoms. N6-methyladenosine (m6A) modification ...
This discovery provides insights into a key RNA modification, N6-methyladenosine (m6A), which is linked to numerous biological processes and diseases, including cancer. mRNA is a type of RNA that ...
Moreover, numerous studies have demonstrated that m6A induces cancer metabolic reprogramming by regulating the expression of core metabolic genes or by activating metabolic signaling pathways.
"m6A is interesting for science because this modification is often altered in people who suffer from metabolic disorders, cancer or heart disease," explains bioinformatician Kathi Zarnack.
The m6A-related lncRNAs were identified by Pearson correlation analysis. Univariate and LASSO regression analyses were used to develop a risk model. The discrimination and predictive ability were ...
By blocking METTL3, a protein that regulates m6A RNA modification, the researchers were able to promote cancer cell differentiation, making the cells more receptive to treatment. The increased ...